Efficacy of Trabectedin in Patients with Advanced Translocation‐Related Sarcomas: Pooled Analysis of Two Phase II Studies

BACKGROUND. Trabectedin is reported as effective, especially against translocation‐related sarcomas (TRSs) after failure of or intolerance to standard chemotherapy. We conducted two phase II studies of TRS, confirming high efficacy of 1.2 mg/m(2) trabectedin. The updated data of 66 patients in these...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Takahashi, Mitsuru, Takahashi, Shunji, Araki, Nobuhito, Sugiura, Hideshi, Ueda, Takafumi, Yonemoto, Tsukasa, Morioka, Hideo, Hiraga, Hiroaki, Hiruma, Toru, Kunisada, Toshiyuki, Matsumine, Akihiko, Shimura, Masashi, Kawai, Akira
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2017
Assuntos:
Sarcomas
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5553952/
https://ncbi.nlm.nih.gov/pubmed/28526720
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0064
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados